Methodological challenges in meditation research

Advances in Mind-Body Medicine

Volumn 21, Issue 1, 2005, Pages 4-11

  Caspi, Opher ^a   Burleson, Katherine O ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE MEDICINE; APTITUDE; COMPETENCE; EXPECTANCY; FEASIBILITY STUDY; HUMAN; HUMAN CHARACTERISTIC; INTERMETHOD COMPARISON; LEARNING; MEDICAL DECISION MAKING; MEDICAL RESEARCH; MEDITATION; METHODOLOGY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; QUALITATIVE RESEARCH; QUANTITATIVE ANALYSIS; RELAXATION TRAINING; REVIEW; TREATMENT OUTCOME; VALIDATION PROCESS;

CLINICAL TRIALS; EVIDENCE-BASED MEDICINE; HUMANS; MEDITATION; RESEARCH DESIGN; SELF EFFICACY; STRESS, PSYCHOLOGICAL;

EID: 18944393973     PISSN: 07419783     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Puryear H, Thurston M. Meditation and the Mind of Man. Virginia Beach, VA: A.R.E. Press; 1975.
2. Barrows KA, Jacobs BP. Mind-body medicine: an introduction and review of the literature. Medical Clinics of North America. 2002;86:11-31.
3. http://nccam.nih.gov/health/whatiscam/index.
4. Bootzin RR, Caspi O. Explanatory mechanisms for placebo effects: cognition, personality, and social learning. In: Guess HA, Kleinman A, Kusek JW, Engel LW, eds. The Science of the Placebo: Toward an Interdisciplinary Research Agenda. London, UK: BMJ Books; 2002.
5. Astin JA, Shapiro SL, Eisenberg DM, Forys KL. Mind-body medicine: state of the science, implications for practice. J Am Board Fam Pract. 2003;16:131-147.
6. Caspi O. The JNC 7 hypertension guidelines. JAMA. 2003;290:1313.
7. Kabat-Zinn J. Mindfulness-based interventions in context: past, present, and future. Clinical Psychology: Science and Practice. 2003;10:144-156.
8. Dunn BR, Hartigan JA, Mikulas WL. Concentration and mindfulness meditations: unique forms of consciousness? Appl Psychophysiol Biofeedback. 1999;24:147-165.
9. Wallace RK, Benson H, Wilson AF. A wakeful hypometabolic physiologic state. Am J Physiol. 1971;221:795-799.
10. Jevning R, Wallace RK, Beidebach M. The physiology of meditation: a review. A wakeful hypometabolic integrated response. Neurosci Biobehav Rev. 1992;16:415-424.
11. Travis F, Olson T, Egenes T, Gupta HK. Physiological patterns during practice of the Transcendental Meditation technique compared with patterns while reading Sanskrit and a modern language. Intl J Neurosci. 2001;109:71-80.
12. Davis PA, Gold EB, Hackman RM, Stern JS, Gershwin ME. The use of complementary/alternative medicine for the treatment of asthma in the United States. J Investig Allergol Clin Immunol. 1998;8:73-77.
13. Shapiro DH, Jr. Overview: clinical and physiological comparison of meditation with other self-control strategies. Am J Psychiatry. 1982;139:267-274.
14. Shadish WR, Cook TC, Campbell DT. Experimental and Quasi-experimental Designs for Generalized Causal Inference. Boston, Mass: Houghton Mifflin Company; 2002.
15. Stone AA. The Science of Self-report: Implications for Research and Practice. Mahwah, NJ: Lawrence Erlbaum; 2000.
16. Cunningham C, Brown S, Kaski JC. Effects of transcendental meditation on symptoms and electrocardiographic changes in patients with cardiac syndrome X. Am J Cardiol. 2000;85:653-655, A610.
17. Schein MH, Gavish B, Herz M, et al. Treating hypertension with a device that slows and regularises breathing: a randomised, double-blind controlled study. J Hum Hypertens. 2001;15:271-278.
18. Bishop SR. What do we really know about mindfulness-based stress reduction? Psychosom Med. 2002;64:71-83.
19. Davidson RJ, Kabat-Zinn J, Schumacher J, et al. Alterations in brain and immune function produced by mindfulness meditation. Psychosom Med. 2003;65:564-570.
20. Travis F, Wallace RK. Autonomic patterns during respiratory suspensions: possible markers of Transcendental Consciousness. Psychophysiol. 1997;34:39-46.
21. Travis F, Wallace RK. Autonomic and EEG patterns during eyes-closed rest and transcendental meditation (TM) practice: the basis for a neural model of TM practice. Conscious Cogn. 1999;8:302-318.
22. Lehmann D, Faber PL, Achermann P, et al. Brain sources of EEG gamma frequency during volitionally meditation-induced, altered states of consciousness, and experience of the self. Psychiatry Res. 2001;108:111-121.
23. Aftanas LI, Golocheikine SA. Human anterior and frontal midline theta and lower alpha reflect emotionally positive state and internalized attention: high-resolution EEG investigation of meditation. Neurosci Lett. 2001;310:57-60.
24. Kubota Y, Sato W, Toichi M, et al. Frontal midline theta rhythm is correlated with cardiac autonomic activities during the performance of an attention demanding meditation procedure. Cogn Brain Res. 2001;11:281-287.
25. Otto MW, Nierenberg AA. Assay sensitivity, failed clinical trials, and the conduct of science. Psychother Psychosom. 2002;71:241-243.
26. Scott AG, Sechrest L. Strength of theory and theory of strength. Evaluation and Program Planning. 1989;12:329-336.
27. Canter PH. The therapeutic effects of meditation. BMJ. 2003;326:1049-1050.
28. Cunningham AJ. Healing through the mind: extending our theories, research and clinical practice. Adv Mind-Body Med. 2001;17:214-227.
29. Caspi O, Bell IR. One size does not fit all: Aptitude x Treatment Interaction (ATI) as a conceptual framework for CAM outcome research. Part I - What is ATI research? J Altern Complem Med. 2004;10:580-586.
30. Caspi O, Bell IR. One size does not fit all: Aptitude x Treatment Interaction (ATI) as a conceptual framework for CAM outcome research. Part II - Research designs and their applications. J Altern Complem Med. 2004;10:698-705.
31. Shoam V, Rohrbaugh M. Aptitude x treatment interaction (ATI) research: Sharpening the focus, widening the lens. In: Aveline M, Shapiro DA, eds. Research Foundation for Psychotherapy Practice. Sussex, England: John Wiley & Sons; 1995:73-95.
32. Karuparthy VR, Vepachedu S. Guggulipid and cholesterol levels. JAMA. 2003;290:2800-2801.
33. Canter PH, Ernst E. Multiple n = 1 trials in the identification of responders and non-responders to the cognitive effects of Ginkgo biloba. Intl J Clin Pharmacol Therapeutics. 2003;41:354-357.
34. Tellegan A. Openness to absorbing and self-altering experiences ("absorption"): a trait related to hypnotic susceptibility J Abnorm Psychol. 1974;83:268-277.
35. Neff DF, Blanchard EB, Andrasik F. The relationship between capacity for absorption and chronic headache patients' response to relaxation and biofeed-back treatment. Biofeedback & Self Regulation. 1983;8:177-183.
36. Shea JD. Effects of absorption and instructions on heart rate control. J Mental Imagery. 1985;9:87.
37. Kalauokalani D, Cherkin DC, Sherman KJ, Koepsell TD, Deyo RA. Lessons from a trial of acupuncture and massage for low back pain: patient expectations and treatment effects. Spine. 2001;26:1418-1424.
38. Schulz KF, Chalmers I, Altman DG. The landscape and lexicon of blinding in randomized trials. Ann Intern Med. 2002; 136:254-259.
39. Schulz KF, Chalmers L, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408-412.
40. Caspi O, Millen C, Sechrest L. Integrity and research: Introducing the concept of dual blindness. How blind are double-blind clinical trials in alternative medicine? J Altern Complem Med. 2000;6:493-498.
41. Caspi O, Bootzin RR. Evaluating how placebos produce change: Logical and causal traps and understanding cognitive explanatory mechanisms. Evaluation & The Health Professions. 2002; 25:436-464.
42. Kutz I, Borysenko JZ, Benson H. Meditation and psychotherapy: a rationale for the integration of dynamic psychotherapy, the relaxation response, and mindfulness meditation. Am J Psychiatry. 1985;142:1-8.
43. Peng CK, Mietus JE, Liu Y, et al. Exaggerated heart rate oscillations during two meditation techniques. Intl J Cardiol. 1999;70:101-107.
44. Bernardi L, Wdowczyk-Szulc J, Valenti C, et al. Effects of controlled breathing, mental activity and mental stress with or without verbalization on heart rate variability J Am College Cardiol. 2000;35:1462-1469.
45. Thomas J, Harden A, Oakley A, et al. Integrating qualitative research with trials in systematic reviews. BMJ. 2004;328:1010-1012.
46. Pincus T. Limitations of randomized clinical trials in chronic diseases: explanations and recommendations. Adv Mind-Body Med. 2002;18:14-21.
47. Donovan J, Mills N, Smith M, et al. Quality improvement report: improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. BMJ. 2002;325:766-770.
48. Cunningham AJ. A new approach to testing the effects of group psychological therapy on length of life in patients with metastatic cancers. Adv Mind-Body Med. 2002;18:5-9.
49. Baer RA. Mindfulness training as a clinical intervention: A conceptual and impirical review. Clin Psychol: Sci Pract. 2003;10:125-143.
50. Lazarus AA, Mayne TJ. Relaxation: some limitations, side effects and proposed solution. Psychother. 1990,27:261-266.
51. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290:1624-1632.
52. ICH Harmonized Tripartite Guideline. E-10: Choice of control group and related issues in clinical trials. 2000.